1,394
Views
5
CrossRef citations to date
0
Altmetric
CASE REPORT

Autologous fat grafting in the treatment of a scleroderma stump-skin ulcer: a case report

ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon & show all
Pages 18-22 | Received 24 Nov 2020, Accepted 22 Jan 2021, Published online: 12 Feb 2021

References

  • Elhai M, Meune C, Avouac J, et al. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology. 2012;51:1017–1026.
  • Ioannidis JPA, Vlachoyiannopoulos PG, Haidich AB, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005;118:2–10.
  • Ferri C, Valentini G, Cozzi F, et al., Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002;81:139–153.
  • Van den Hoogen F, Khanna D, Fransen J, et al. 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–2747.
  • Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40:78–83.
  • Ferri C, Sebastiani M, Lo Monaco A, et al. Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients’ population and review of the literature. Autoimmun Rev. 2014; 13:1026–1034.
  • Walker UA, Tyndall A, Czirják L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research Group database. Ann Rheum Dis. 2007;66:754–763.
  • Steen V, Denton CP, Pope JE, et al. Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford). 2009;48:iii19–iii24.
  • Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg. 2006;118:108S–120S.
  • Rigotti G, Marchi A, Galie M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. 2007; 119:1409–1422. discussion 1423-4.
  • Klinger M, Caviggioli F, Klinger FM, et al. Autologous fat graft in scar treatment. J Craniofac Surg. 2013;24:1610–1615.
  • Juhl AA, Karlsson P, Damsgaard TE. Fat grafting for alleviating persistent pain after breast cancer treatment: a randomized controlled trial. J Plast Reconstr Aesthet Surg. 2016; 69:1192–1202.
  • Coleman SR, Katzel EB. Fat grafting for facial filling and regeneration. Clin Plast Surg. 2015; 42:289–300, vii.
  • Rigotti G, Charles-de-Sá L, Gontijo-de-Amorim NF, et al. Expanded stem cells, stromal-vascular fraction, and platelet-rich plasma enriched fat: comparing results of different facial rejuvenation approaches in a clinical trial. Aesthet Surg J. 2016;36:261–270.
  • Kowal-Bielecka O, Landewé R, Avouac J, et al., EUSTAR Co-Authors. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis. 2009;68:620–628.
  • Giuggioli D, Manfredi A, Colaci M, et al. Scleroderma digital ulcers complicated by infection with fecal pathogens. Arthritis Care Res (Hoboken). 2012;64:295–297.
  • Coleman SR. Hand rejuvenation with structural fat grafting. Plast Reconstr Surg. 2002; 110:1731–1744. discussion 1745-7.
  • Pu LL, Coleman SR, Cui X, et al. Autologous fat grafts harvested and refined by the Coleman technique: a comparative study. Plast Reconstr Surg. 2008;122:932–937.
  • Fantozzi F. Hand rejuvenation with fat grafting: a 12-year single-surgeon experience. Eur J Plast Surg. 2017;40:457–464.
  • Bourne DA, Thomas RD, Bliley J, et al. Amputation-site soft-tissue restoration using adipose stem cell therapy. Plast Reconstr Surg. 2018;142:1349–1352.
  • Malik P, Gaba S, Ahuja C, et al. Role of fat graft alone versus enriched fat graft with stromal vascular filtrate in painful amputation stump. Indian J Orthop. 2019;53:452–458.
  • Gimble JM, Katz AJ, Bunnel BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100:1249–1260.
  • Bora P, Majumdar AS. Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther. 2017;8:145
  • Simonacci F, Bertozzi N, Raposio E. Off-label use of adipose-derived stem cells. Ann Med Surg (Lond). 2017;24:44–51.
  • Frazier T, Alarcon A, Wu X, et al. Clinical translational potential in skin wound regeneration for adipose-derived, blood-derived, and cellulose materials: cells, exosomes, and hydrogels. Biomolecules. 2020;10:1373.
  • Denton CP. Systemic sclerosis: from pathogenesis to target therapy. Clin Exp Rheumatol. 2015; 33:3–7.
  • Capelli C, Zaccara E, Cipriani P, et al. Phenotypical and functional characteristics of in vitro-expanded adipose-derived mesenchymal stromal cells from patients with systematic sclerosis. Cell Transplant. 2017; 26:841–854.
  • Magalon J, Velier M, Simoncini S, et al. Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis. Ann Rheum Dis. 2019;78:391–398.
  • Manetti M. Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis? Ann Rheum Dis. 2020;79:e55.
  • Del Papa N, Di Luca G, Andracco R, et al. Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study. Arthritis Res Ther. 2019;21:7.
  • Del Papa N, Di Luca G, Sambataro D, et al. Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long lasting indolent digital ulcers in patients with systemic sclerosis. Cell Transplant. 2015; 24:2297–2305.
  • Scuderi N, Ceccarelli S, Onesti MG, et al. Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transplant. 2013; 22:779–795.
  • Granel B, Daumas A, Jouve E, et al. Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis. 2015;74:2175–2182.
  • Strong AL, Rubin JP, Kozlow JH, et al. Fat grafting for the treatment of scleroderma. Plast Reconstr Surg. 2019;144:1498–1507.
  • Chen B, Wang X, Long X, et al. Supportive use of adipose-derived stem cells in cell-assisted lipotransfer for localized scleroderma. Plast Reconstr Surg. 2018; 141:1395–1407.
  • Pignatti M, Spinella A, Cocchiara E, et al. Autologous fat grafting for the oral and digital complications of systemic sclerosis: results of a prospective study. Aesthetic Plast Surg. 2020;44:1820–1832.
  • Bene MD, Pozzi MR, Rovati L, et al. Autologous fat grafting for scleroderma-induced digital ulcers. An effective technique in patients with systemic sclerosis. Handchir Mikrochir Plast Chir. 2014;46:242–247.